GenomeNet

Database: UniProt
Entry: PPARG_RABIT
LinkDB: PPARG_RABIT
Original site: PPARG_RABIT 
ID   PPARG_RABIT             Reviewed;         475 AA.
AC   O19052;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   27-MAR-2024, entry version 151.
DE   RecName: Full=Peroxisome proliferator-activated receptor gamma;
DE            Short=PPAR-gamma;
DE   AltName: Full=Nuclear receptor subfamily 1 group C member 3;
GN   Name=PPARG; Synonyms=NR1C3;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=New Zealand white;
RX   PubMed=9275054; DOI=10.1210/endo.138.9.5373;
RA   Michael L.F., Lazar M.A., Mendelson C.R.;
RT   "Peroxisome proliferator-activated receptor gamma1 expression is induced
RT   during cyclic adenosine monophosphate-stimulated differentiation of
RT   alveolar type II pneumonocytes.";
RL   Endocrinology 138:3695-3703(1997).
CC   -!- FUNCTION: Nuclear receptor that binds peroxisome proliferators such as
CC       hypolipidemic drugs and fatty acids. Once activated by a ligand, the
CC       nuclear receptor binds to DNA specific PPAR response elements (PPRE)
CC       and modulates the transcription of its target genes, such as acyl-CoA
CC       oxidase. It therefore controls the peroxisomal beta-oxidation pathway
CC       of fatty acids. Key regulator of adipocyte differentiation and glucose
CC       homeostasis. ARF6 acts as a key regulator of the tissue-specific
CC       adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut
CC       homeostasis by suppressing NF-kappa-B-mediated pro-inflammatory
CC       responses. Plays a role in the regulation of cardiovascular circadian
CC       rhythms by regulating the transcription of BMAL1 in the blood vessels.
CC       {ECO:0000250|UniProtKB:P37231, ECO:0000250|UniProtKB:P37238}.
CC   -!- ACTIVITY REGULATION: PDPK1 activates its transcriptional activity
CC       independently of its kinase activity. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with FOXO1 (acetylated form) (By similarity).
CC       Heterodimer with other nuclear receptors, such as RXRA. The heterodimer
CC       with the retinoic acid receptor RXRA is called adipocyte-specific
CC       transcription factor ARF6. Interacts with NCOA6 coactivator, leading to
CC       a strong increase in transcription of target genes. Interacts with
CC       coactivator PPARBP, leading to a mild increase in transcription of
CC       target genes. Interacts with NOCA7 in a ligand-inducible manner.
CC       Interacts with NCOA1 and NCOA2 LXXLL motifs. Interacts with ASXL1,
CC       ASXL2, DNTTIP2, FAM120B, MAP2K1/MEK1, NR0B2, PDPK1, PRDM16, PRMT2 and
CC       TGFB1I1. Interacts (when activated by agonist) with PPP5C. Interacts
CC       with HELZ2 and THRAP3; the interaction stimulates the transcriptional
CC       activity of PPARG. Interacts with PER2, the interaction is ligand
CC       dependent and blocks PPARG recruitment to target promoters. Interacts
CC       with NOCT. Interacts with ACTN4. Interacts (when in the liganded
CC       conformation) with GPS2 (By similarity). Interacts with CRY1 and CRY2
CC       in a ligand-dependent manner (By similarity). In the absence of
CC       hormonal ligand, interacts with TACC1 (By similarity).
CC       {ECO:0000250|UniProtKB:P37231, ECO:0000250|UniProtKB:P37238}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00407}.
CC       Cytoplasm {ECO:0000250}. Note=Redistributed from the nucleus to the
CC       cytosol through a MAP2K1/MEK1-dependent manner. NOCT enhances its
CC       nuclear translocation (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors.
CC       {ECO:0000250|UniProtKB:P37231}.
CC   -!- PTM: Phosphorylated at basal conditions and dephosphorylated when
CC       treated with the ligand. May be dephosphorylated by PPP5C. The
CC       phosphorylated form may be inactive and dephosphorylation induces
CC       adipogenic activity (By similarity). {ECO:0000250|UniProtKB:P37231}.
CC   -!- PTM: Ubiquitinated by E3 ubiquitin-protein ligase complex containing
CC       FBXO9; leading to proteasomal degradation (By similarity).
CC       Ubiquitinated at Lys-222 by TRIM55 leading to proteasomal degradation
CC       (By similarity). {ECO:0000250|UniProtKB:P37231,
CC       ECO:0000250|UniProtKB:P37238}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U84893; AAB96380.1; -; mRNA.
DR   AlphaFoldDB; O19052; -.
DR   BMRB; O19052; -.
DR   SMR; O19052; -.
DR   STRING; 9986.ENSOCUP00000043929; -.
DR   PaxDb; 9986-ENSOCUP00000018424; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   InParanoid; O19052; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0070888; F:E-box binding; ISS:UniProtKB.
DR   GO; GO:0004879; F:nuclear receptor activity; ISS:UniProtKB.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB.
DR   GO; GO:0010742; P:macrophage derived foam cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0048384; P:retinoic acid receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   CDD; cd06965; NR_DBD_Ppar; 1.
DR   CDD; cd06932; NR_LBD_PPAR; 1.
DR   Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 1.
DR   Gene3D; 1.10.565.10; Retinoid X Receptor; 1.
DR   InterPro; IPR003074; 1Cnucl_rcpt.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR003077; PPAR-gamma.
DR   InterPro; IPR022590; PPARgamma_N.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   PANTHER; PTHR24082; NUCLEAR HORMONE RECEPTOR; 1.
DR   PANTHER; PTHR24082:SF488; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF12577; PPARgamma_N; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR01288; PROXISOMEPAR.
DR   PRINTS; PR01291; PROXISOMPAGR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 1.
DR   SUPFAM; SSF48508; Nuclear receptor ligand-binding domain; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   2: Evidence at transcript level;
KW   Activator; Biological rhythms; Cytoplasm; DNA-binding; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Receptor; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..475
FT                   /note="Peroxisome proliferator-activated receptor gamma"
FT                   /id="PRO_0000053496"
FT   DOMAIN          208..473
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        106..180
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         109..129
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         146..168
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          175..250
FT                   /note="Interaction with FAM120B"
FT                   /evidence="ECO:0000250"
FT   MOTIF           465..473
FT                   /note="9aaTAD"
FT                   /evidence="ECO:0000250|UniProtKB:P37231"
FT   MOD_RES         82
FT                   /note="Phosphoserine; by MAPK"
FT                   /evidence="ECO:0000250|UniProtKB:P37238"
FT   CROSSLNK        222
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P37231"
SQ   SEQUENCE   475 AA;  54365 MW;  FA2688295310D9E7 CRC64;
     MVDTEMPFWP TNFGIGSVDL SVMDDHSHSF DIKPFTTVDF SSISAPHYED LPFARADPMV
     ADYKYDLKLQ EYQSAIKVEP ASPPYYSEKT QLYNKTHEEP SNSLMAIECR VCSDKASGFH
     YGVHACEGCK GFFRRTIRLK LIYDRCDLNC RIHKKSRNKC QYCRFQKCLA VGMSHNAIRF
     GRMPQAEKEK LLAEISSDID QLNPESADLR ALAKHLYDSY IKSFPLTKAK ARAILTGKTT
     DKSPFVIYDM NSLMMGEDKI KFKHITPLQE QSKEVAIRIF QGCQFRSVEA VQEITEYAKN
     IPGFVSLDLN DQVTLLKYGV HEIIYTMLAS LMNKDGVLIS EGQGFMTREF LKSLRKPFGD
     FMEPKFEFAV KFNALELDDS DLAIFIAVII LSGDRPGLLN VKPIEDIQDN LLQALELQLK
     LNHPEASQLF AKLLQKMTDL RQIVTEHVQL LQVIKKTETD MSLHPLLQEI YKDLY
//
DBGET integrated database retrieval system